Immediate Impact
2 by Nobel laureates 50 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Daniel Hirschhorn being referenced
Abstract 1699: Treatment with agonist anti-GITR antibody after chemotherapy enhances tumor immunity
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Hirschhorn | 29 | 17 | 1 | 12 | 5 | 38 | |
| Véronique Laplante | 16 | 18 | 1 | 26 | 4 | 43 | |
| Pauline M. R. Bardet | 34 | 23 | 1 | 19 | 6 | 49 | |
| Jose Enrique Alés Martínez | 33 | 6 | 1 | 16 | 4 | 44 | |
| Teagan Wagner | 39 | 30 | 2 | 12 | 6 | 53 | |
| Deepthi Rajagopalan | 17 | 6 | 1 | 11 | 5 | 31 | |
| Dmitriy Ponomarenko | 13 | 15 | 6 | 5 | 36 | ||
| Felix Bayerl | 27 | 20 | 2 | 15 | 4 | 48 | |
| Veronika Haunerdinger | 13 | 16 | 3 | 15 | 6 | 35 | |
| Michelle Hillman | 50 | 27 | 10 | 4 | 57 | ||
| Abderezak Zebboudj | 18 | 21 | 2 | 22 | 5 | 55 |
All Works
Login with ORCID to disown or claim papers
Loading papers...